GABAB receptor antibodies in paraneoplastic cerebellar ataxia

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 94-96

  Jarius, Sven ^a   Steinmeyer, Florian ^b   Knobel, Astrid ^b   Streitberger, Kaspar ^b   Hotter, Benjamin ^b   Horn, Sigrun ^c   Heuer, Heike ^c   Schreiber, Stephan J ^b   Wilhelm, Tabea ^b   Trefzer, Uwe ^b   Wildemann, Brigitte ^a   Ruprecht, Klemens ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

Cerebellar ataxia; GABAB receptor antibodies; Indirect immunofluorescence; Interferon alpha; Malignant melanoma; Paraneoplastic neurological syndrome

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; ATAXIA; AUTOIMMUNITY; BLOOD CELL COUNT; BRAIN TISSUE; CASE REPORT; CEREBELLAR ATAXIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCYTOPENIA; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC CEREBELLAR ATAXIA; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEIZURE;

ANTIBODIES; BRAIN; CELL LINE, TRANSFORMED; CEREBELLAR ATAXIA; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, GABA-B;

EID: 84875367214     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.12.006     Document Type: Article

References (11)

1. Bataller L., Sabater L., Saiz A., Serra C., Claramonte B., Graus F. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann. Neurol. 2004, 56:575-579.
2. Bettler B., Kaupmann K., Mosbacher J., Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 2004, 84:835-867.
3. Boronat A., Sabater L., Saiz A., Dalmau J., Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 2011, 76:795-800.
4. Bouwhuis M.G., Suciu S., Testori A., Kruit W.H., Sales F., Patel P., Punt C.J., Santinami M., Spatz A., Ten Hagen T.L., Eggermont A.M. Phase III trial comparing adjuvant treatment with pegylated interferon alfa-2b versus observation: prognostic significance of autoantibodies - EORTC 18991. J. Clin. Oncol. 2010, 28:2460-2466.
5. Graus F., Saiz A., Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J. Neurol. 2010, 257:509-517.
6. Lancaster E., Lai M., Peng X., Hughes E., Constantinescu R., Raizer J., Friedman D., Skeen M.B., Grisold W., Kimura A., Ohta K., Iizuka T., Guzman M., Graus F., Moss S.J., Balice-Gordon R., Dalmau J. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010, 9:67-76.
7. Onishi S., Nagashima T., Kimura H., Matsuyama Y., Yoshio T., Minota S. Systemic lupus erythematosus and Sjogren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C. Lupus 2010, 19:753-755.
8. Saiz A., Blanco Y., Sabater L., Gonzalez F., Bataller L., Casamitjana R., Ramio-Torrenta L., Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
9. Tanaka J., Sugimoto K., Shiraki K., Beppu T., Yoneda K., Fuke H., Yamamoto N., Ito K., Takei Y. Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C. Intern. Med. 2008, 47:747-749.
10. Tomer Y. Hepatitis C and interferon induced thyroiditis. J. Autoimmun. 2010, 34:J322-J326.
11. Zuliani L., Graus F., Giometto B., Bien C., Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J. Neurol. Neurosurg. Psychiatry 2012, 83:638-645.